All posts by medical

Physiology

Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications – DocWire News

This article was originally published here

Front Neurosci. 2020 Oct 6;14:572965. doi: 10.3389/fnins.2020.572965. eCollection 2020.

ABSTRACT

Gangliosides are glycosphingolipids highly abundant in the nervous system, and carry most of the sialic acid residues in the brain. Gangliosides are enriched in cell membrane microdomains (lipid rafts) and play important roles in the modulation of membrane proteins and ion channels, in cell signaling and in the communication among cells. The importance of gangliosides in the brain is highlighted by the fact that loss of function mutations in ganglioside biosynthetic enzymes result in severe neurodegenerative disorders, often characterized by very early or childhood onset. In addition, changes in the ganglioside profile (i.e., in the relative abundance of specific gangliosides) were reported in healthy aging and in common neurological conditions, including Huntingtons disease (HD), Alzheimers disease (AD), Parkinsons disease (PD), amyotrophic lateral sclerosis (ALS), stroke, multiple sclerosis and epilepsy. At least in HD, PD and in some forms of epilepsy, experimental evidence strongly suggests a potential role of gangliosides in disease pathogenesis and potential treatment. In this review, we will summarize ganglioside functions that are crucial to maintain brain health, we will review changes in ganglioside levels that occur in major neurological conditions and we will discuss their contribution to cellular dysfunctions and disease pathogenesis. Finally, we will review evidence of the beneficial roles exerted by gangliosides, GM1 in particular, in disease models and in clinical trials.

PMID:33117120 | PMC:PMC7574889 | DOI:10.3389/fnins.2020.572965

Read the original:
Gangliosides in the Brain: Physiology, Pathophysiology and Therapeutic Applications - DocWire News

Genetics

Race, genetics, and their impact on health – Mumbai Mirror

Amongst the various forms of discriminations the world has seen, Apartheid, a system of institutionalised racial segregation practised in South Africa, was one of the worst. I went to medical school with several South African students and the stories of discrimination they told me about were horrifying. Thankfully Apartheid, which was based on white supremacy and lasted more than 40 years, ended in the early 1990s.

I am often asked by my Caucasian friends if I felt discriminated against in the UK because of my brownness. I reply that it may have been true in early 1970s. I remember waiting in line to be served a pint of beer, only to be ignored by the proprietor of the pub. When I had the good fortune of going with a white girl, there was never a problem getting served.

Of course things have changed in the UK, which is today a proudly multicultural country. Overt discrimination of the kind that existed earlier is no longer tolerated. Asian communities especially are a thriving group, eagerly courted by political parties. Today when I go to a pub in London, I find the barmaid waiving me in.

This brings us to the topic of todays column: the role of race in health outcomes. Differences in health status, life expectancy and other indicators in different racial and ethnic groups are well documented. But before we get to that, let me get a somewhat controversial subject out of the way: the dominance of black athletes.

Black athletes enjoy a huge over-representation at the highest level of many sports - from the 100 metres sprint through to the marathon, every single record is currently held by athletes of African origin.

Sir Roger Bannister, who ran the first sub-4-minute mile, said in a speech to the British Association of Advancement of Science in 1995 that heel-bone length, subcutaneous fat and differences in the length of the Achilles tendon may explain the advantage that Africans may have in running sports. A study published in the Journal of Applied Physiology reported that Africans display an enhanced resistance to fatigue while running on a treadmill. There are tens of such studies - many of them controversial - which are beyond the scope of one column.

Coming back to race and health outcomes: Diabetes, for example, is 60 per cent more common among African Americans than white Americans. Black Americans are 2.5 times more likely to suffer limb amputations and 5.5 times likely to suffer from kidney disease because of diabetes.

Blacks in America are more likely to die of asthma than whites and, despite lower tobacco exposure, Blacks are 50 per cent more likely to get lung cancer.

Black Americans suffer twice the risk of stroke than Whites; strokes kill four times more 35- to 54-year-old Blacks than white. Black men have a 40 per cent high cancer death rate, and women 20 per cent higher death rate, than their white counterparts.

The stats for the other major minority group in America - the hispanics - are similarly depressing.

Around 15 years ago, the US FDA controversially approved a drug called BiDil for a single racial-ethnic group - African Americans - for treatment of congestive heart failure. The scientific research leading to BiDils approval tested the drug only in African American populations.

Craig Venter, the famous American biotechnologist who produced the map of the human genome, said it was disturbing to see things categorised in terms of race.

Is race really a surrogate marker for describing human genetic variation? In India genetics and race are certainly considered interchangeable. People still prefer getting married to someone of their own community. One of the major consequence of endogamy - the practice of marrying within the same community - is genetic diseases arising out of a limited gene pool. We would certainly be better off if we looked to widen our gene pool.

Read more here:
Race, genetics, and their impact on health - Mumbai Mirror

Genetics

Your Dog Could Have the Same Genetic Makeup as Canines Living During the Ice Age – Yahoo Lifestyle

Your Dog Could Have the Same Genetic Makeup as Canines Living During the Ice Age

There are at least five types of dogs that have DNA tying to breeds from 11,000 years ago, according to a new study.

Is your dog your very best companion? We understand. There's a good reason that canines are said to be a man'sor woman'sbest friend. But just how long exactly have dogs been around? A group of researchersconsisting of scientists from the Francis Crick Institute, the University of Oxford, the University of Vienna, and archaeologists from over 10 countriespublished a study in the journal Science that just gave their answer. According to the article, titled "Origins and Genetic Legacy of Prehistoric Dogs," the team dug deep to discover that the genetic makeup of the modern dog traces back to the end of the Ice Agewhich means your dogs are actually connected to some of the most ancient pet species, CNN reports.

Hillary Kladke / Getty Images

To come to their findings, the scientists studied the DNA from ancient dog bones. From there, they found that there were five types of dogs with specific genetics that came out of the Ice Age. These dogs have "mixed and combined" lineages that are still found in the everyday dog today. The researchers uncovered that Rhodesian ridgebacks have ties to DNA from an ancient Middle Eastern or African lineage, Siberian huskies have genetic makeup from an ancient Siberian lineage, and dogs like chihuahuas and Mexican hairless dogs have some pre-Columbian DNA.

Related: The Most Low-Energy, Non-Shedding Dog Breeds

Anders Bergstrom, the lead author and post-doctoral researcher in the Ancient Genomics Laboratory at London's Francis Crick Institute, also shared that canines have been housebroken and found worldwide for some time now. "Already by 11,000 years agobefore agriculture, and before any other animal had been domesticateddogs had not only been domesticated, but they had already diversified genetically and likely spread across large parts of the world."

Bergstrom added, though, that the mixing of DNA is common in dogs. "All dog breeds from Europe share a common history that started with an ancient mixture, many thousands of years ago, between two very distinct dog lineagesone related to dogs in the Near East, and the other related to dogs in Siberia. This ancient mixing event between these two lineages gave rise to the European dog gene pool which later would give rise to all present-day European dog breeds," he said. "We find that when we compare the history of dogs to the history of humans, to a quite large degree they mirror each other, suggesting that in many cases, the history of dogs has been shaped by humans. In many cases humans would simply bring their dogs with them as they migrated and moved across the world."

Visit link:
Your Dog Could Have the Same Genetic Makeup as Canines Living During the Ice Age - Yahoo Lifestyle

Genetics

Scientists Assemble Full Genomes for Domesticated Apple and Two of Its Wild Progenitors – Technology Networks

The fabled Silk Road - the 4,000-mile stretch between China and Western Europe where trade flourished from the second century B.C. to the 14th century A.D. - is responsible for one of our favorite and most valuable fruits: the domesticated apple (Malus domestica).

Snack-packing travelers would pick apples at one spot, eat them and toss their cores many miles away. The seeds grew into trees in their new locations, cross-bred with the wild species, and created more than 7,000 varieties of apples that exist today.

Hybridizations with wild species have made the apple genome very complex and difficult to study. A global team of multi-disciplinary researchers - co-led byZhangjun Fei,faculty member at Boyce Thompson Institute (BTI), andGan-Yuan Zhong, scientist with the USDA-Agricultural Research Service (ARS) in Geneva, New York - tackled this problem by applying cutting-edge sequencing technologies and bioinformatics algorithms to assemble complete sets of both chromosomes for the domesticated apple and its two main wild progenitors.

The researchers discovered that the apple's unique domestication history has led to untapped sources of genes that could be used for crop improvement, such as improving size, flavor, sweetness and texture.

"Plant breeders could use this detailed information to improve upon traits that matter most to consumers, which today is primarily flavor," says Fei, also an adjunct associate professor in Cornell University's School of Integrative Plant Science (SIPS).

"Perhaps more importantly," he added, "the information will help breeders produce apples that are more resistant to stress and disease."

The research is described in apaperpublished inNature Geneticson November 2, with authors from BTI, Cornell University, Cornell AgriTech, the U.S. Department of Agriculture (USDA) and Shandong Academy of Agricultural Sciences.

Follow-up discussions among Fei, Zhong and other colleagues at Cornell, inspired them to build better and new apple reference genomes by applying new sequencing and assembly technologies to material in USDA's Geneva Clonal Repository. The repository, which is housed atCornell AgriTech, holds the largest collection of apple accessions in the world. Many of these accessions can be traced back to the Silk Road.

In the current work, the researchers sequenced, assembled and compared the full reference genomes for three species: Gala, a top commercial cultivar of M. domestica; and apple's two main wild progenitors, the European crabapple (M. sylvestris) and the central Asian wild apple (M. sieversii), which together account for about 90% of the domesticated apple's genome.

The results provide apple breeders with detailed genomic roadmaps that could help them build a better apple.

"We wanted to develop new genomes, especially the wild progenitors, because of the tremendous impact they could have on understanding apple's genetic diversity and identifying useful traits for breeding new cultivars," said Zhong, who is also an adjunct associate professor in SIPS.

By comparing the three genomes, the researchers were able to identify which progenitor species contributed the genes responsible for many traits in the domesticated apple. For example, the team found that the gene giving apple its crunchy texture is located near the gene that makes it susceptible to blue mold.

"Now that we know exactly where those two genome regions are," Fei said, "breeders could figure out a way to keep the texture gene and breed out or edit out the blue mold gene to produce a more disease-resistant cultivar."

The team identified about 50,000 genes in the pan-genome of the domesticated apple, including about 2,000 that were not present in previously published reference genomes for apple species. "These 'missing genes' turn out to be really important, because many of them determine the traits of greatest interest to apple breeders," Fei said.

Using RNA extracted from different stages of Gala fruits, they also identified genes linked to texture, aroma and other fruit characteristics that were preferentially expressed between the two copies of the genes.

"That provides us and breeders with an even deeper understanding of the genetic diversity underlying a particular trait," Zhong said. "The findings will help our group better manage and curate more than 6,000 apple accessions in the USDA Geneva Clonal Repository," Zhong adds, "as well as enable us to provide critical genetic and genomic information associated with the accessions to breeders and other researchers."

Reference: Sun X, Jiao C, Schwaninger H, et al. Phased diploid genome assemblies and pan-genomes provide insights into the genetic history of apple domestication. Nature Genetics. 2020. doi:10.1038/s41588-020-00723-9.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read the original here:
Scientists Assemble Full Genomes for Domesticated Apple and Two of Its Wild Progenitors - Technology Networks

Genetics

Benchmark : Genetics has signed a 5-year ova agreement with AquaCon – Marketscreener.com

3 November 2020

The contract between Benchmark Genetics and AquaCon involves deliveries of genetics to the land-based facilities that AquaCon are planning to build in Maryland, USA. Benchmark's Icelandic company, StofnFiskur, will supply approximately 40 million ova to AquaCon over five years. The agreement confirms and consolidates Benchmark's strong position as a genetics supplier to land-based farming worldwide.

Benchmark Genetics has been producing land-based broodstock and ova in Iceland since the early 1990s and has long-standing experience with land-based salmon farming worldwide. Geir Olav Melingen, Commercial Director at Benchmark Genetics, considers this a clear competitive advantage when selling to new land-based projects:

'As a leading supplier to land-based farming, we have gradually gained comprehensive experience in securing deliveries to destinations all over the world. Since we keep our broodstock on land and thereby have full control over the maturation and spawning, we are in the position to produce and deliver ova to customers every single week of the year. The term 'egg season' is outdated with us'.

Security of supply was an essential factor for why AquaCon chose the company as a supplier.

Pl Haldorsen is the CEO of AquaCon, which currently has a head office in Oslo and shortly plans to go public. 'We have chosen to secure genetics at an early stage, as we consider ova as a key strategic success factor of our ambitious growth plans', he says.

Haldorsen explains that Benchmark Genetics satisfies AquaCon's requirements for the security of supply, biosecurity and genetic traits adapted to land-based RAS farming:

'Our production plan presupposes regular deliveries of ova throughout the year, and Benchmark Genetics has a production model for land-based broodstock that makes us confident that we will receive deliveries following our plans'.

Located on the south-west shore of Iceland, StofnFiskur's land-based facilities have no other salmon farms nearby. The intake water, both freshwater and seawater, comes from boreholes and is entirely pathogen-free. StofnFiskur's four farms are approved according to the OIE compartment standard, meaning that the zones around each farm are defined as entirely isolated and protected from external disease threats. As an example, Benchmark Genetics is the only genetics company approved by Sernapesca for export of ova to Chile.

'The unique location and production model makes us confident that we can deliver eggs that have the highest biosafety standard to AquaCon,' says Geir Olav Melingen.

Geir Olav also proudly says that all energy used for broodstock and ova production in Iceland comes exclusively from renewable sources. Thus, the production has a relatively low CO2 footprint, even though land-based production is often considered energy-intensive.

Benchmark Genetics strongly believes that significant parts of the future growth in salmon farming will come from land-based production. Therefore, the company has developed production concepts and products that are adapted to the specific needs of this part of the industry.

'The genetic weighting of growth and quality traits forms the foundation of our product, SalmoRAS4 +. Besides, we have also developed methods in the production of broodstock that produce offspring that will not become sexually mature. This means that the operations like AquaCon can produce at higher temperatures to optimize growth', says Melingen.

'We, therefore, have great faith that land-based farming in the future will be competitive on production costs compared to traditional sea-farming', Geir Olav Melingen concludes.

Disclaimer

Benchmark Holdings plc published this content on 03 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2020 09:34:02 UTC

Read more:
Benchmark : Genetics has signed a 5-year ova agreement with AquaCon - Marketscreener.com

Neuroscience

Meet The First Black Woman To Earn a Ph.D. in Neuroscience from the University of Rochester – Because of Them We Can

She's a whole scholar!

Dr. Monique Mendes just made history as the first Black woman to earn a Ph.D. in neuroscience from the University of Rochester, Diverse Education reports.

Mendes is a native of Jamaica who had to make several adjustments to get used to the American culture and education system when moving to the United States. Nonetheless, she persisted, attending public schools and eventually pursuing her undergraduate education at the University of Florida, where she majored in biology. It was during that time, working in the lab, where she discovered her love for neuroscience.

"[The lab] is where I had real hands-on experiences working on a project from the beginning all the way to the end. I had to do all the experiments, and I helped with writing the paper. That was where I realized that it was really exciting to be a part of science," Mendes told Diverse Education.

While at the University of Florida, she joined the McNair Scholars Program, which supports undergrad students with mentorship, financial assistance, and other resources in preparation for a doctoral degree. After earning her bachelor's degree, she enrolled at the University of Rochester Medical Center's (URMC) Del Monte Institute for Neuroscience to pursue her doctorate. As a first-generation college student, she depended on mentorship from faculty members and credited them with her success.

"I definitely had no idea what was going on in the beginning. I was fortunate to have a number of mentors throughout my career that really put my success as a priority. Throughout the years, I gained the experience and the resources I needed to succeed," Mendes told reporters.

She excelled during her time in graduate school. Mendes received several accolades, including "being appointed as a fellow of the Neuroscience Scholars Program by the Society for Neuroscience. She [became] the first URMC graduate student to receive the F99/K00 NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience fellowship from the National Institute of Neurological Disorders in Stroke, and receiving the Edward Peck Curtis Award for Excellence in Teaching by a graduate student."

This past summer, Mendes defended her dissertation, "The Kinetics of Microglial Ontogeny and Maturation in the Adult Brain," a study about how cells renew and mature in the brain. Upon graduation, she was surprised to discover that she was the first Black woman in the history of URMC to receive a Ph.D. in neuroscience.

"I felt really incredibly empowered because I felt like I was setting the stage for more Black women to come to Rochester where they can feel like this is something they can do and something they can be successful at. Hopefully, I showed other women that this was possible," she told Diverse Education.

Mendes said that in hindsight, she didn't have one other person who looked like her in any of her classes during her time at the University. She found community elsewhere, finding other Black women in her field through social media campaigns like #BlackInNeuro. She hopes her journey can inspire other women to get into the field and says the burden is on schools and companies to create more opportunities for Black women in the sector.

"I would say create an environment that is not only diverse but inclusive and also paying attention to the cultures so that Black women can feel that this is a place for them. There is a seat at the table. I just think that's probably the most important thing," Mendes told reporters.

The neuroscientist is currently a postdoctoral fellow at Stanford University, where she plans to study how glia cells impact memory and learning. She hopes to transition to a faculty position in the future and become an advocate and mentor for other students.

When she's not working in the lab, she plays violin and plans to join a community orchestra. Mendes began playing violin at the Immaculate Conception High School in Jamaica. She has played at weddings and the Florida Youth Orchestra, the Brighton Symphony Orchestra, and the Rochester Philharmonic Orchestra here in the United States.

"It is a sense of community," Mendes told reporters. "It is nice to have something outside of science to relax. Surprisingly, orchestra is relaxing for me. People would think otherwise. But it feels good to have like a cohort of people that you can talk about something that you are all passionate about. I have had a lot of fun over the years."

Congratulations, Dr. Mendes!

Photo Courtesy of URMC Rochester

Continue reading here:
Meet The First Black Woman To Earn a Ph.D. in Neuroscience from the University of Rochester - Because of Them We Can

Neuroscience

Neuroscience Antibodies and Assays Market Extensive Growth Opportunities to Be Witnessed by 2020-2028 – The Think Curiouser

The Neuroscience Antibodies and Assays Market report makes Accessible Today and Forthcoming financial and technical details of this business. Some of those chief insights of the business report comprise; different analysis of the market drivers & restraints, important market players engaged like business, detailed evaluation of their market segmentation & aggressive evaluation. It quotes CAGR values in proportions which help to be familiar with increase or fall happening in the marketplace for specific product for the particular prediction interval. International Neuroscience Antibodies and Assays Market report additionally encompasses tactical profiling of important players on the current market, systematic evaluation of the core competencies & brings a competitive landscape for the marketplace.

Request Sample Report @ https://beathanreports.com/request-for-sample-report/9621

The Neuroscience Antibodies and Assays Market report may be employed by both Conventional and new players from the market for whole knowhow of this marketplace. The business evaluation report brings into consideration important industry trends, market sizeand market share prices, and revenue quantity which help business to speculate that the approaches to boost return on investment (ROI). In addition, the industry record holds a considerable significance as its all about describing market definition, classifications, software and engagements. Together with the analysis of competition analysis conducted within this Neuroscience Antibodies and Assays Market report, the business can get fluency of these plans of important players on the marketplace which contains new product launches, expansions, arrangements, joint ventures, partnerships, and acquisitions.

Market Evaluation: Global Neuroscience Antibodies and Assays Market

Global Neuroscience Antibodies and Assays economy is set to see a Significant CAGR Of XX percent at the forecasted period of 2019-2026. This increase in the marketplace can be credited because of improvement in autoimmune identification and technology progress in the business.

The following players are covered in this report:

Thermo Fisher

Abcam

Bio-Rad

Merck

Cell Signaling Technology

Genscript

Rockland Immunochemicals

BioLegend

Santa Cruz Biotechnology

Roche

Siemens

Neuroscience Antibodies and Assays

Request Discount About This Report @ https://beathanreports.com/discount-request-on-report/9621

Breakdown Data by Type

Consumables

Instruments

Neuroscience Antibodies and Assays Breakdown Data by Application

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Hospitals & Diagnostic Centers

Table of Contents : Neuroscience Antibodies and Assays Market

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Request For Customization About This Report @ https://beathanreports.com/request-for-customization/9621

Contact Us

Beathan Report,

4004 W Lake Sammamish,

Pkway B9 Redmond,

WA 98052 United States.

Tel: +44 115 888 3028

Web: http://www.beathanreports.com

About Us

At Beathan Report, we understand that the research we provide is only as good as the outcome it inspires. These reports are generated by well-renowned publishers on the basis of the data acquired from an extensive research and credible business statistics. Thats why we are proud to provide the widest range of research products, multilingual 24/7 customer support and dedicated custom research services to deliver the insights you need to achieve your goals. Take a look at few of our aspects that makes Beathan Report an asset to your business.

See the rest here:
Neuroscience Antibodies and Assays Market Extensive Growth Opportunities to Be Witnessed by 2020-2028 - The Think Curiouser

Neuroscience

Neuroscience Market 2020-2025 | Comprehensive Study COVID19 Impact Analysis | Global Key Players: GE Healthcare, Siemens Healthineers, Noldus…

The Neuroscience market study Added by Affluence Market Reports, provides an in-depth analysis pertaining to potential drivers fueling this industry. The research report on the Neuroscience market consists of significant information regarding the growth drivers, opportunities, and the challenges & restraints that define the business scenario in the subsequent years.

The report offers valuable insight into the Neuroscience market progress and approaches related to the Neuroscience market with an analysis of each region. The report goes on to talk about the dominant aspects of the market and examine each segment

Request for Sample Copy of Neuroscience Market with Complete TOC and Figures & Graphs @ https://www.affluencemarketreports.com/industry-analysis/request-sample/693855/

Key Players:

The global Neuroscience market has been comprehensively analyzed and the different companies that occupy a large percentage of the market share in the regions mentioned have been listed out in the report. Industry trends that are popular and are causing a resurgence in the market growth are identified. A strategic profile of the companies is also carried out to identify the various subsidiaries that they own in the different regions and who are responsible for daily operations in these regions.

The Key Players Covered in Neuroscience Market Study are:

For more Customization in Neuroscience Market Report:https://www.affluencemarketreports.com/industry-analysis/request-inquiry/693855/

Neuroscience Market Segmentation:

Neuroscience market is split by Type and by Application. For the period 2018-2025, the growth among segments provides accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market Segmentation by Type:

Market Segmentation by Applications:

Impact of COVID-19 on Neuroscience Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Neuroscience Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international market. The epidemic has immediately interrupted the requirement and supply series. The Neuroscience Market report also assesses the economic effect on firms and monetary markets. Futuristic Reports has accumulated advice from several delegates of this business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

For More Details on Impact of COVID-19 on Neuroscience Market:https://www.affluencemarketreports.com/industry-analysis/covid19-request/693855/

Regional Analysis Covered in this Report are:

Frequently Asked Questions

Get a Discount on Neuroscience Market Report @https://www.affluencemarketreports.com/industry-analysis/request-discount/693855/

About Affluence:

Affluence Market Reports is the next generation of all your research needs with a strong grapple on the worldwide market for industries, organizations, and governments. Our aim is to deliver exemplary reports that meet the definite needs of clients, which offers an adequate business technique, planning, and competitive landscape for new and existing industries that will develop your business needs.

We provide a premium in-depth statistical approach, a 360-degree market view that includes detailed segmentation, key trends, strategic recommendations, growth figures, Cost Analysis, new progress, evolving technologies, and forecasts by authentic agencies.

For more Details Contact Us:

Affluence Market Reports

Contact Person: Mr. Rohit

Phone Number: U.S +1-(424) 256-1722

Email: sales[emailprotected]

Website: http://www.affluencemarketreports.com

Follow this link:
Neuroscience Market 2020-2025 | Comprehensive Study COVID19 Impact Analysis | Global Key Players: GE Healthcare, Siemens Healthineers, Noldus...

Neuroscience

What Does the Future Hold for Neuroscience Antibodies and Assays Market? – Zenit News

Researchmoz has published a research report on the Neuroscience Antibodies and Assays market. The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the report. It provides an in-depth analysis of the Neuroscience Antibodies and Assays market segments which include products, applications, and end-user applications.

This report also includes a complete analysis of industry players that cover their latest developments, product portfolio, pricing, mergers, acquisitions, and collaborations. Moreover, it provides crucial strategies that are helping them to expand their market share. The Global Neuroscience Antibodies and Assays Market research report is prepared by implying robust research methodology and including Porters Five Forces analysis to provide the complex matrix of the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2815134&source=atm

Key Highlights of the Report

The Neuroscience Antibodies and Assays market report covers the comprehensive analysis from the period of 2020-2026. It also provides the historic data of the market that has impacted positively or negatively to the market growth.

Regulatory policies and investment scenarios of the market are curated in a concise manner.

Top-winning market strategies and vital product offerings from the industry players.

A neutral perspective on the Neuroscience Antibodies and Assays market.

The broad analysis of the emerging trends in the market that helps to identify new market avenues and lucrative opportunities. Moreover, it aids in identifying product segments to maximize revenue and expand the market share.

This report highlights the market propellants, challenges, and threats in the market.

Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.researchmoz.com/enquiry.php?type=S&repid=2815134&source=atm

Market Segmentation Covered in the report.

segment by Type, the product can be split into2D Cell Models3D Cell ModelsCommercial 3D Cell ModelsInhouse 3D Cell Models

Market segment by Application, split intoDrug ScreeningToxicology3D Model DevelopmentBasic ResearchPhysiologic ResearchStem Cell ResearchRegenerative Medicine

Based on regional and country-level analysis, the Lungs in Vitro market has been segmented as follows:North AmericaUnited StatesCanadaEuropeGermanyFranceU.K.ItalyRussiaNordicRest of EuropeAsia-PacificChinaJapanSouth KoreaSoutheast AsiaIndiaAustraliaRest of Asia-PacificLatin AmericaMexicoBrazilMiddle East & AfricaTurkeySaudi ArabiaUAERest of Middle East & Africa

The market research report is classified into the types of products and is analyzed in a detailed manner. Moreover, it includes potential future products that are expected to open new market avenues and can change the dynamics of the market. Each product type is analyzed on the basis of their developments, growth, and threats in the different regions.

This report covers all the applications of the afore-mentioned products and also provides information on the potential applications in the foreseeable future. The dedicated research team has to look into all possible parameters and analyzed the applications that drive the growth of the market.

By Region

North America (U.S., Canada, Mexico)

Asia Pacific (India, China, Japan, South Korea, ASEAN, Rest of Asia Pacific)

Europe (Italy, Germany, France, Spain, Central & Eastern Europe, Rest of Europe)

Middle East & Africa (GCC, Turkey, Rest of the Middle East & Africa)

South America (Brazil, Argentina, Rest of South America)

One country of interest can be added with no additional cost on the report. Moreover, if more than one needs to be added, the regional segment quote may vary. In this report, the questions such as which country/region is expected to witness a steep rise in CAGR & year-on-year (Y-o-Y) are also covered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2815134&source=atm

In the competitive analysis section of the report, leading as well as prominent players of the global Lungs in Vitro market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.The key players covered in this studyATCCLonzaEpithelixMattekEmulateMimetasTissuseInspheroCn Bio

Note: Additional companies can be profiled in the report.

Frequently asked questions (FAQs) about the report

1) Does the report cover COVID-19 impact and future market projections?

Yes. The market research report covers the detailed analysis of COVID-19 impact on the market. Our research team has been monitoring the market closely while it has been conducting interviews with the industry experts to get better insights on the present and future implications of the COVID-19 virus on the market.

The market report provides vital information on the strategies deployed by industry players during the COVID-19 crisis to maintain their position in the market. Along with this, it also shares crucial data on product developments due to the inevitable pandemic across the globe.

2) Can the report be customized according to the requirements?

Yes. The Neuroscience Antibodies and Assays market report can be customized according to your needs. For instance, the company can be profiled you ask for while specific region/country analysis can be focused that meets your interests. You can talk to our research analyst about your exact requirements and UMR will accordingly tailor the required report.

3) Can we narrow the available business segments?

Yes, the market report can be further segmented on the basis of data availability and feasibility. We can provide a further breakdown in product types and applications (if applicable) by size, volume, or revenue. In the market segmentation part, the latest product developments and customer behavior insights are also included to give an in-depth analysis of the market.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2815134&licType=S&source=atm

See the article here:
What Does the Future Hold for Neuroscience Antibodies and Assays Market? - Zenit News

Neuroscience

Here’s What Sugar Really Does to Your Brain, According to a Neuroscience Expert – msnNOW

Aleksandra Medvedeva - Getty Images A donut for breakfast, sweetened yogurt for lunch, a mid-afternoon syrupy latte here's how sugar affects your bain.

Sugar rush. Sugar high. Sugar buzz. Sugar slump.

Weve all heard these phrases that describe what our brains feel like when weve had too much of a sweet treat. But heres the thing about sugar and your brain: Your noggin needs it because sugar is its main fuel. Our brains run on glucoseit fuels our cells, including our brain cells. Were evolutionarily programmed to like sweets since theyre a great energy source. And when glucose levels are low in the blood (say, if you have hypoglycemia, or sometimes if it's just been a while since youve had something to eat), brain fog sets in, you fumble for words, you forget where you put down your phone, you look for a place to curl up for a quick nap.

When theres too much sugar in the system, however, that can set off some really bad stuff in your body and your brain.

When sugar hits our tongue, it activates certain taste buds that send a signal up to the brain, including the cerebral cortex, says Nicole Avena, Ph.D., assistant professor of neuroscience at Mount Sinai School of Medicine, who wrote a book about sugar addiction. The signal activates the brains reward system; dopamine (a feel-good brain chemical) is released and the behavior is reinforced, which makes us want to repeat it (mmmm, thats nice, give me more!).

Sugar is rare among dopamine-producing foods, Avena points out. Most of the time when we eat something new and tasty, dopamine is released the first time we taste it, she explains. This is an evolutionary advantage to help us to pay attention to new and different tastes, in case they make us sick. If we eat something new and dont get sick, typically the dopamine response then goes away the next timeso basically we only release dopamine in response to eating new foods. However, sugar is different. Its more like what happens with a drug of abuse, where dopamine is released every single time its consumed. Eating lots of sugar will continue to feel rewarding because the dopamine level doesnt balance out, which it does when eating healthier foods. So sugar does act a bit like a drug in our systemwhich is why people get hooked on sugary foods.

Gallery: 8 Healthy Eating Habits for Men (Eat This, Not That!)

We used to have to forage for sweet foodsbut no more, of course. Our world is filled with sugary foodsand not just the obvious donuts and super-sweetened, super-large latte drinks. A host of surprising foodsfrom ketchup to salad dressing to marinara sauce have sugar added to them. But our brains still function like sugar is a rarity.

When you repeatedly activate that reward system, your brain adapts and actually rewires itself, and you crave more and more. And research on rats turned up this finding: When they were fed high-sugar diets, the rats brains released less of a certain chemical that helps bodies put on the brakes, so they were less able to stop eating it.

Those sugar-saturated rats also werent as good at certain memory tasks, which showed that certain brain functions in the prefrontal area and hippocampus (an important area for memory formation and retention) were impaired. Other rat studies showed that a high sugar diet increased inflammation in this area, which also affected short term memory.

$17.81

Shop Now

You may not be aware that theres a strong connection between our gut and our brainand sugar comes into play here as well. When that sugary thing youve eaten hits your gut, Avena says, it activates sugar receptors there too, which signal the brain to release insulin to deal with the extra sugar youve eaten. To explain further: Excess sugar drives the pancreas to produce extra insulin, a hormone involved in blood sugar regulation. The insulin signals fat cells to store excessive amounts of glucose, fatty acids, and other calorie-rich substances. As a result, too few calories remain in the bloodstream, so the brain thinks its now low on fuel (since it has those very high energy needs). So your hunger level rises quickly. And sugar is appealing then because it provides quick energy. Thus, the cycle begins again. And thus, cravings for more and more brownies or ice cream or candy.

Want to get your brain in line with a healthier sugar level? Your brain can readapt when you cut back on sugar, and you wont crave it as much, says Avena. However, it can take awhile, even months, for this to happen, depending on the severity of dependence on sugar that one has.

To find out more about how to start cutting back on sugar and shake off a sugar dependence, try a 7-day detox plan. When you can successfully cut back, there's a payoff, besides a much healthier body: Just a small taste of, say, that delicious chocolate brownie will be enough of a sweet treat to satisfy you.

Try 200+ at home workout videos from Mens Health, Womens Health, Prevention, and more on All Out Studio free for 14 days!

See the original post here:
Here's What Sugar Really Does to Your Brain, According to a Neuroscience Expert - msnNOW